Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

BACKGROUND: Higher serum phosphate and fibroblast growth factor-23 (FGF23) levels may be modifiable to prevent cardiovascular disease in CKD. Short-term studies have reported modest efficacy in phosphate and FGF23 reduction with intestinal phosphate binders in CKD. METHODS: To investigate effects of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Soc Nephrol
Hlavní autoři: Ix, Joachim H., Isakova, Tamara, Larive, Brett, Raphael, Kalani L., Raj, Dominic S., Cheung, Alfred K., Sprague, Stuart M., Fried, Linda F., Gassman, Jennifer J., Middleton, John P., Flessner, Michael F., Block, Geoffrey A., Wolf, Myles
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Nephrology 2019
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551774/
https://ncbi.nlm.nih.gov/pubmed/31085679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101058
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky